Repligen Corp (RGEN US)

Analysis

Health Care • United States

Repligen Corporation is a bioprocessing company focused on the development, production, and commercialization of innovative products used in the process of manufacturing biologic drugs. The Company's customers include life sciences companies, global biopharmaceutical companies, and contract manufacturers worldwide.

Refresh

Company Presentation • 10 Sep 2026 01:30

Wells Fargo 21st Annual Healthcare Conference

Company Presentation • 28 Jul 2026 20:00

Q2 2026

Company Presentation • 22 Jul 2026 20:30

M&A announcement

Company Presentation • 03 Jun 2026 23:40

46th Annual William Blair Growth Stock Conference

Company Presentation • 05 May 2026 20:00

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Wells Fargo 21st Annual Healthcare Conference

Q2 2026

M&A announcement

46th Annual William Blair Growth Stock Conference

Q1 2026